Silgan (SLGN) Financials

$39.18 -0.13 (-0.32%)

Closing price 05/13/2026 03:59 PM Eastern

Extended Trading

$39.16 -0.03 (-0.06%)

As of 08:05 AM Eastern

Annual Income Statements for Silgan

This table shows Silgan's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	172	153	270	224	194	309	359	341	326	276	288
Consolidated Net Income / (Loss)	172	153	270	224	194	309	359	341	326	276	288
Net Income / (Loss) Continuing Operations	172	153	270	224	194	309	359	341	326	276	288
Total Pre-Tax Income	253	232	240	293	252	407	466	474	422	348	409
Total Operating Income	320	300	357	412	359	512	576	602	595	515	598
Total Gross Profit	554	512	635	690	714	867	918	1,048	993	1,012	1,149
Total Revenue	3,764	3,613	4,090	4,449	4,490	4,922	5,677	6,411	5,988	5,855	6,483
Operating Revenue	3,764	3,613	4,090	4,449	4,490	4,922	5,677	6,411	5,988	5,855	6,483
Total Cost of Revenue	3,210	3,101	3,455	3,759	3,776	4,055	4,759	5,364	4,996	4,843	5,334
Operating Cost of Revenue	3,210	3,101	3,455	3,759	3,776	4,055	4,759	5,364	4,996	4,843	5,334
Total Operating Expenses	234	212	278	278	354	355	342	446	397	497	552
Selling, General & Admin Expense	220	220	305	308	316	378	378	417	384	438	493
Restructuring Charge	14	19	5.83	6.25	56	16	15	74	8.41	59	61
Other Special Charges / (Income)	-	-27	-33	-37	-18	-39	-51	-45	4.33	-1.19	-1.62
Total Other Income / (Expense), net	-67	-68	-117	-119	-107	-105	-110	-128	-173	-167	-189
Interest Expense	67	68	117	119	107	105	110	128	173	167	189
Income Tax Expense	80	79	-30	69	58	98	107	133	96	72	123
Other Gains / (Losses), net	-	-	-	-	-	-	-	0.00	0.00	0.69	3.16
Basic Earnings per Share	$1.41	$1.28	$2.44	$2.03	$1.75	$2.79	$3.25	$3.09	$3.00	$2.59	$2.71
Weighted Average Basic Shares Outstanding	61.02M	119.73M	110.35M	110.60M	110.78M	110.06M	110.41M	110.08M	106.50M	106.79M	105.44M
Diluted Earnings per Share	$1.41	$1.27	$2.42	$2.01	$1.74	$2.77	$3.23	$3.07	$2.98	$2.58	$2.70
Weighted Average Diluted Shares Outstanding	61.02M	119.73M	110.35M	110.60M	110.78M	110.06M	110.41M	110.08M	106.50M	106.79M	105.44M
Weighted Average Basic & Diluted Shares Outstanding	61.02M	119.73M	110.35M	110.60M	110.78M	110.06M	110.41M	110.08M	106.50M	106.79M	105.44M
Cash Dividends to Common per Share	$0.32	$0.68	$0.36	$0.40	$0.44	$0.48	$0.56	$0.64	$0.72	$0.76	$0.80

This table shows Silgan's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	111	64	55	76	100	45	68	89	113	18	63
Consolidated Net Income / (Loss)	111	64	55	76	100	45	68	89	113	18	63
Net Income / (Loss) Continuing Operations	111	64	55	76	100	45	68	89	113	18	63
Total Pre-Tax Income	147	84	73	101	125	49	88	119	149	53	84
Total Operating Income	194	126	112	142	167	94	131	168	199	101	127
Total Gross Profit	286	219	223	256	293	239	270	299	327	253	266
Total Revenue	1,803	1,340	1,317	1,381	1,745	1,411	1,467	1,539	2,009	1,469	1,561
Operating Revenue	1,803	1,340	1,317	1,381	1,745	1,411	1,467	1,539	2,009	1,469	1,561
Total Cost of Revenue	1,517	1,122	1,094	1,125	1,452	1,172	1,196	1,240	1,681	1,216	1,295
Operating Cost of Revenue	1,517	1,122	1,094	1,125	1,452	1,172	1,196	1,240	1,681	1,216	1,295
Total Operating Expenses	92	92	112	114	126	145	140	132	129	152	139
Selling, General & Admin Expense	84	97	100	108	106	124	129	122	122	120	131
Restructuring Charge	6.42	-4.80	12	6.86	19	21	11	9.86	7.19	32	9.05
Other Special Charges / (Income)	1.08	0.67	-0.41	-0.41	0.12	-0.49	-0.19	-0.14	-0.81	-0.49	-1.04
Total Other Income / (Expense), net	-47	-42	-39	-41	-42	-46	-43	-49	-50	-48	-42
Interest Expense	47	42	39	41	42	46	43	49	50	48	42
Income Tax Expense	36	19	18	24	25	4.29	21	30	36	36	22
Other Gains / (Losses), net	-	-	0.00	0.00	0.00	-	1.16	0.56	0.78	0.67	1.20
Basic Earnings per Share	$1.02	$0.61	$0.52	$0.71	$0.94	$0.42	$0.64	$0.83	$1.06	$0.18	$0.60
Weighted Average Basic Shares Outstanding	108.42M	106.50M	106.65M	106.84M	106.85M	106.79M	106.92M	107.05M	106.62M	105.44M	105.59M
Diluted Earnings per Share	$1.02	$0.60	$0.52	$0.71	$0.93	$0.42	$0.63	$0.83	$1.06	$0.18	$0.60
Weighted Average Diluted Shares Outstanding	108.75M	106.50M	107.05M	107.02M	107.14M	106.79M	107.34M	107.25M	106.80M	105.44M	105.86M
Weighted Average Basic & Diluted Shares Outstanding	106.50M	106.50M	106.78M	106.78M	106.79M	106.79M	106.99M	106.99M	105.67M	105.44M	105.68M
Cash Dividends to Common per Share	$0.18	-	$0.19	$0.19	$0.19	-	$0.20	$0.20	$0.20	-	$0.21

This table details how cash moves in and out of Silgan's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-123	-75	29	19	131	206	222	-46	57	180	258
Net Cash From Operating Activities	336	395	390	507	507	603	557	748	483	722	730
Net Cash From Continuing Operating Activities	336	395	390	507	507	603	557	748	483	722	730
Net Income / (Loss) Continuing Operations	172	153	270	224	194	309	359	341	326	276	288
Consolidated Net Income / (Loss)	172	153	270	224	194	309	359	341	326	276	288
Depreciation Expense	142	143	174	192	206	219	250	263	263	276	319
Amortization Expense	4.16	4.14	4.26	3.77	3.46	4.54	5.57	5.46	5.37	5.47	5.53
Non-Cash Adjustments To Reconcile Net Income	26	32	28	24	75	36	97	92	24	76	79
Changes in Operating Assets and Liabilities, net	-9.48	62	-86	63	28	34	-155	47	-136	88	38
Net Cash From Investing Activities	-237	-180	-1,198	-190	-230	-1,163	-976	-216	-224	-1,176	-297
Net Cash From Continuing Investing Activities	-237	-180	-1,198	-190	-230	-1,163	-976	-216	-224	-1,176	-297
Purchase of Property, Plant & Equipment	-237	-192	-174	-191	-231	-224	-232	-216	-227	-263	-307
Acquisitions	-0.69	0.00	-1,024	0.00	0.00	-941	-746	-2.50	0.00	-922	0.00
Sale of Property, Plant & Equipment	0.90	-	-	-	-	-	2.80	3.35	1.76	7.80	10
Other Investing Activities, net	-	12	0.60	1.05	0.85	1.87	-0.82	-0.69	1.24	0.26	-0.25
Net Cash From Financing Activities	-221	-289	837	-294	-146	760	649	-570	-211	663	-207
Net Cash From Continuing Financing Activities	-221	-289	837	-294	-146	760	649	-570	-211	663	-207
Repayment of Debt	-767	-865	-2,089	-1,280	-462	-1,831	-2,106	-1,120	-60	-1,147	-763
Repurchase of Common Equity	-173	-281	-4.12	-7.83	-28	-42	-8.57	-45	-184	-9.32	-75
Payment of Dividends	-40	-41	-40	-45	-51	-54	-62	-72	-79	-82	-86
Issuance of Debt	740	919	2,961	1,043	400	2,681	2,685	835	12	1,977	704
Other Financing Activities, net	19	-23	8.85	-4.13	-4.66	5.20	140	-167	99	-76	12
Effect of Exchange Rate Changes	-	0.00	0.00	-3.70	-0.74	6.47	-7.53	-9.03	9.91	-28	33
Cash Interest Paid	64	65	98	118	109	90	102	124	155	160	185
Cash Income Taxes Paid	50	58	70	47	41	121	94	94	116	92	104

This table details how cash moves in and out of Silgan's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	71	336	-334	-5.85	66	454	-470	-36	72	691	-645
Net Cash From Operating Activities	216	1,079	-548	21	313	936	-683	-221	341	1,294	-800
Net Cash From Continuing Operating Activities	216	1,079	-548	21	313	936	-683	-221	341	1,294	-800
Net Income / (Loss) Continuing Operations	111	64	55	76	100	45	68	89	113	18	63
Consolidated Net Income / (Loss)	111	64	55	76	100	45	68	89	113	18	63
Depreciation Expense	65	67	66	66	67	77	79	76	83	81	85
Amortization Expense	1.35	1.34	1.35	1.35	1.35	1.43	1.41	1.20	1.29	1.62	1.63
Non-Cash Adjustments To Reconcile Net Income	11	-0.58	16	11	23	26	15	13	12	38	16
Changes in Operating Assets and Liabilities, net	28	947	-687	-133	122	786	-847	-401	131	1,155	-965
Net Cash From Investing Activities	-54	-53	-72	-56	-61	-987	-82	-63	-81	-70	-80
Net Cash From Continuing Investing Activities	-54	-53	-72	-56	-61	-987	-82	-63	-81	-70	-80
Purchase of Property, Plant & Equipment	-55	-53	-75	-56	-61	-71	-83	-73	-80	-71	-82
Sale of Property, Plant & Equipment	0.95	0.13	2.50	0.49	0.24	4.58	0.05	9.50	0.20	0.28	2.07
Other Investing Activities, net	0.70	-0.03	0.30	-0.25	-0.34	0.55	0.40	-0.10	-1.59	1.04	0.40
Net Cash From Financing Activities	-86	-699	293	36	-195	528	283	231	-188	-533	234
Net Cash From Continuing Financing Activities	-86	-699	293	36	-195	528	283	231	-188	-533	234
Repayment of Debt	-39	-845	-115	-60	-235	-709	-712	-46	-892	888	-706
Repurchase of Common Equity	-153	-0.05	-7.68	-0.06	-	-1.58	-6.87	-	-59	-8.74	-7.84
Payment of Dividends	-19	-19	-21	-20	-20	-20	-22	-21	-21	-21	-23
Issuance of Debt	125	5.79	598	142	63	1,174	1,111	299	786	-1,492	1,069
Other Financing Activities, net	-0.69	160	-161	-25	-2.01	85	-86	-1.08	-1.54	101	-99
Effect of Exchange Rate Changes	-5.18	9.41	-6.69	-	-	-23	13	18	0.77	0.56	0.53
Cash Interest Paid	43	31	50	41	43	27	51	53	45	37	52
Cash Income Taxes Paid	11	20	17	27	26	22	12	33	17	42	7.88

This table presents Silgan's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	3,193	3,149	4,645	4,579	4,931	6,512	7,771	7,346	7,611	8,585	9,397
Total Current Assets	1,045	962	1,292	1,290	1,407	1,799	2,296	2,133	2,349	2,523	2,992
Cash & Equivalents	100	25	54	73	204	409	631	586	643	823	1,081
Accounts Receivable	281	288	455	511	505	620	711	658	600	594	589
Inventories, net	628	603	721	635	633	678	799	769	941	928	1,080
Prepaid Expenses	36	46	62	71	65	93	154	120	166	177	242
Plant, Property, & Equipment, net	1,125	1,157	1,490	1,518	0.00	0.00	1,994	1,931	1,962	2,283	2,378
Total Noncurrent Assets	1,022	1,030	1,864	1,772	3,524	4,712	3,481	3,282	3,301	3,779	4,027
Goodwill	613	605	1,171	1,148	1,142	1,741	2,038	1,985	2,018	2,316	2,487
Intangible Assets	195	181	417	383	355	637	831	764	721	869	900
Other Noncurrent Operating Assets	214	245	275	240	2,027	2,334	612	533	561	594	640
Total Liabilities & Shareholders' Equity	3,193	3,149	4,645	4,579	4,931	6,512	7,771	7,346	7,611	8,585	9,397
Total Liabilities	2,553	2,680	3,879	3,698	3,908	5,259	6,208	5,628	5,722	6,595	7,123
Total Current Liabilities	781	862	958	1,079	1,019	1,192	1,509	1,438	2,312	2,248	2,452
Short-Term Debt	152	217	109	170	30	28	20	80	880	717	632
Accounts Payable	477	505	660	713	727	803	1,133	974	1,076	1,112	1,252
Accrued Expenses	107	94	124	127	195	231	246	285	258	310	447
Current Employee Benefit Liabilities	45	46	66	69	67	130	109	99	98	109	121
Total Noncurrent Liabilities	1,772	1,818	2,921	2,619	2,889	4,067	4,700	4,190	3,410	4,348	4,671
Long-Term Debt	1,361	1,344	2,439	2,134	2,215	3,223	3,773	3,345	2,546	3,420	3,715
Noncurrent Deferred & Payable Income Tax Liabilities	-	298	262	268	255	356	435	389	434	506	502
Other Noncurrent Operating Liabilities	411	175	220	217	420	488	491	456	430	422	454
Total Equity & Noncontrolling Interests	639	469	766	881	1,023	1,253	1,563	1,718	1,889	1,990	2,274
Total Preferred & Common Equity	639	469	766	881	1,023	1,253	1,563	1,718	1,889	1,990	2,274
Total Common Equity	639	469	766	881	1,023	1,253	1,563	1,718	1,889	1,990	2,274
Common Stock	238	251	264	278	291	308	327	342	356	370	387
Retained Earnings	1,446	1,559	1,810	1,998	2,141	2,395	2,692	2,961	3,208	3,403	3,605
Accumulated Other Comprehensive Income / (Loss)	-209	-224	-189	-269	-260	-261	-260	-345	-251	-353	-214
Other Equity Adjustments	-	-	-	-	-	-	-	-	-1,423	-	-1,504

This table presents Silgan's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	7,519	7,862	7,914	7,812	7,574	7,693	7,747	8,768	9,410	9,498	9,322
Total Current Assets	2,332	2,625	2,698	2,662	2,376	2,539	2,519	2,597	3,009	3,112	2,967
Cash & Equivalents	244	501	237	307	309	303	369	353	317	389	435
Accounts Receivable	1,124	936	1,068	1,296	946	1,057	1,210	1,013	1,242	1,503	1,159
Inventories, net	851	1,055	1,252	919	957	1,006	780	1,055	1,259	1,022	1,129
Prepaid Expenses	113	133	143	140	164	173	160	176	191	198	244
Plant, Property, & Equipment, net	1,887	1,930	1,934	1,912	1,944	1,934	1,956	2,303	2,382	2,393	2,355
Total Noncurrent Assets	3,301	3,307	3,281	3,239	3,254	3,221	3,272	3,868	4,019	3,993	4,000
Goodwill	1,915	2,002	2,007	1,980	1,997	1,987	2,024	2,373	2,485	2,481	2,465
Intangible Assets	758	756	745	724	702	685	681	890	907	892	879
Other Noncurrent Operating Assets	628	549	528	535	555	549	566	605	628	620	657
Total Liabilities & Shareholders' Equity	7,519	7,862	7,914	7,812	7,574	7,693	7,747	8,768	9,410	9,498	9,322
Total Liabilities	5,826	6,080	6,043	6,030	5,674	5,760	5,693	6,685	7,188	7,226	7,002
Total Current Liabilities	1,681	1,844	1,880	1,916	2,289	2,396	2,306	2,285	3,135	2,451	2,358
Short-Term Debt	591	785	811	898	1,346	1,398	1,254	1,145	1,937	1,135	988
Accounts Payable	688	716	752	652	610	658	679	737	757	852	817
Accrued Expenses	291	241	222	269	234	239	266	284	317	335	432
Current Employee Benefit Liabilities	110	102	95	96	100	101	106	119	122	129	121
Total Noncurrent Liabilities	4,145	4,236	4,163	4,115	3,385	3,364	3,388	4,399	4,054	4,775	4,644
Long-Term Debt	3,247	3,370	3,351	3,313	2,535	2,531	2,554	3,483	3,115	3,812	3,672
Noncurrent Deferred & Payable Income Tax Liabilities	425	389	384	380	432	425	421	487	479	511	516
Other Noncurrent Operating Liabilities	473	477	427	422	418	408	413	429	460	452	456
Total Equity & Noncontrolling Interests	1,693	1,781	1,871	1,782	1,900	1,934	2,054	2,083	2,222	2,272	2,321
Total Preferred & Common Equity	1,693	1,781	1,871	1,782	1,900	1,934	2,054	2,083	2,222	2,272	2,321
Total Common Equity	1,693	1,781	1,871	1,782	1,900	1,934	2,054	2,083	2,222	2,272	2,321
Common Stock	338	344	347	351	358	362	366	373	376	381	391
Retained Earnings	2,954	3,013	3,072	3,163	3,243	3,299	3,378	3,449	3,516	3,608	3,646
Accumulated Other Comprehensive Income / (Loss)	-365	-325	-280	-310	-272	-298	-261	-303	-235	-222	-206
Other Equity Adjustments	-1,233	-1,251	-1,269	-1,423	-1,429	-1,429	-1,429	-1,435	-	-1,495	-1,510

This table displays calculated financial ratios and metrics derived from Silgan's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-3.78%	-4.01%	13.20%	8.78%	0.92%	9.62%	15.34%	12.94%	-6.60%	-2.23%	10.73%
EBITDA Growth	-9.16%	-4.13%	19.78%	13.51%	-6.28%	29.26%	13.04%	4.59%	-0.71%	-7.82%	15.83%
EBIT Growth	-11.37%	-6.28%	19.10%	15.44%	-12.77%	42.53%	12.44%	4.49%	-1.08%	-13.49%	16.07%
NOPAT Growth	-5.73%	-9.10%	102.65%	-21.64%	-12.20%	40.62%	14.17%	-2.46%	6.25%	-11.17%	2.21%
Net Income Growth	-5.47%	-11.06%	75.84%	-16.93%	-13.47%	59.29%	16.31%	-5.08%	-4.37%	-15.21%	4.35%
EPS Growth	-50.70%	-9.93%	90.55%	-16.94%	-13.43%	59.20%	16.61%	-4.95%	-2.93%	-13.42%	4.65%
Operating Cash Flow Growth	-3.58%	17.51%	-1.21%	29.96%	0.16%	18.75%	-7.58%	34.40%	-35.52%	49.58%	1.10%
Free Cash Flow Firm Growth	-43.25%	3.37%	-448.17%	154.17%	-29.47%	-297.29%	71.01%	421.82%	-42.47%	-164.39%	181.36%
Invested Capital Growth	-0.90%	-2.26%	62.48%	-4.50%	-1.58%	33.64%	15.38%	-3.52%	2.53%	13.49%	4.47%
Revenue Q/Q Growth	-2.10%	-0.65%	4.87%	1.71%	-0.49%	3.76%	3.89%	0.25%	-1.89%	1.23%	0.89%
EBITDA Q/Q Growth	-0.83%	0.95%	10.31%	-0.68%	0.31%	6.36%	4.79%	-4.98%	6.93%	-2.58%	1.19%
EBIT Q/Q Growth	-2.02%	-0.10%	10.60%	-2.16%	-1.61%	7.00%	4.29%	-7.32%	8.17%	-5.83%	1.17%
NOPAT Q/Q Growth	1.73%	-1.55%	84.55%	-32.45%	-2.67%	7.90%	6.92%	-12.46%	12.41%	-3.39%	-8.60%
Net Income Q/Q Growth	1.72%	-1.83%	83.15%	-32.52%	-1.70%	8.91%	7.46%	-15.06%	13.92%	-6.55%	-8.52%
EPS Q/Q Growth	-48.91%	323.33%	120.00%	-32.55%	-1.69%	9.06%	7.31%	-14.72%	14.18%	-6.52%	-8.16%
Operating Cash Flow Q/Q Growth	-4.96%	6.15%	-2.96%	24.36%	3.33%	-4.09%	16.43%	68.15%	78.81%	-16.52%	96.30%
Free Cash Flow Firm Q/Q Growth	-36.06%	42.77%	-1.91%	37.43%	-26.30%	-5.23%	56.11%	15.50%	2,913.15%	-136.11%	120.51%
Invested Capital Q/Q Growth	-16.10%	-18.99%	-7.66%	-14.95%	-12.52%	-8.46%	-11.06%	-13.80%	-17.80%	-3.46%	-18.89%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	14.72%	14.17%	15.52%	15.50%	15.90%	17.62%	16.18%	16.34%	16.58%	17.28%	17.73%
EBITDA Margin	12.38%	12.37%	13.09%	13.66%	12.68%	14.95%	14.66%	13.57%	14.43%	13.60%	14.23%
Operating Margin	8.50%	8.30%	8.73%	9.26%	8.01%	10.41%	10.15%	9.39%	9.94%	8.80%	9.22%
EBIT Margin	8.50%	8.30%	8.73%	9.26%	8.01%	10.41%	10.15%	9.39%	9.94%	8.80%	9.22%
Profit (Net Income) Margin	4.58%	4.24%	6.59%	5.03%	4.32%	6.27%	6.33%	5.32%	5.44%	4.72%	4.45%
Tax Burden Percent	68.18%	66.12%	112.51%	76.37%	76.87%	75.84%	77.00%	71.89%	77.22%	79.49%	70.60%
Interest Burden Percent	79.07%	77.38%	67.14%	71.17%	70.14%	79.45%	80.94%	78.77%	70.89%	67.50%	68.33%
Effective Tax Rate	31.82%	33.88%	-12.51%	23.63%	23.13%	24.16%	23.00%	28.11%	22.78%	20.70%	30.17%
Return on Invested Capital (ROIC)	10.57%	9.77%	15.25%	9.88%	8.95%	10.86%	10.06%	9.32%	9.96%	8.19%	7.70%
ROIC Less NNEP Spread (ROIC-NNEP)	7.29%	6.73%	8.70%	6.04%	5.08%	7.59%	7.24%	6.26%	5.20%	3.86%	3.78%
Return on Net Nonoperating Assets (RNNOA)	14.99%	17.90%	28.40%	17.32%	11.41%	16.27%	15.45%	11.45%	8.11%	6.06%	5.83%
Return on Equity (ROE)	25.56%	27.67%	43.65%	27.19%	20.35%	27.13%	25.51%	20.78%	18.07%	14.25%	13.53%
Cash Return on Invested Capital (CROIC)	11.48%	12.06%	-32.35%	14.48%	10.54%	-17.94%	-4.22%	12.91%	7.47%	-4.45%	3.33%
Operating Return on Assets (OROA)	9.89%	9.45%	9.16%	8.93%	7.56%	8.96%	8.07%	7.96%	7.96%	6.36%	6.65%
Return on Assets (ROA)	5.33%	4.84%	6.92%	4.86%	4.08%	5.40%	5.03%	4.51%	4.36%	3.41%	3.21%
Return on Common Equity (ROCE)	25.56%	27.67%	43.65%	27.19%	20.35%	27.13%	25.51%	20.78%	18.07%	14.25%	13.53%
Return on Equity Simple (ROE_SIMPLE)	26.97%	32.67%	35.20%	25.42%	18.94%	24.64%	22.98%	19.84%	17.25%	13.89%	0.00%
Net Operating Profit after Tax (NOPAT)	218	198	402	315	276	389	444	433	460	408	417
NOPAT Margin	5.79%	5.49%	9.82%	7.07%	6.15%	7.90%	7.81%	6.75%	7.68%	6.98%	6.44%
Net Nonoperating Expense Percent (NNEP)	3.29%	3.04%	6.55%	3.84%	3.86%	3.27%	2.82%	3.06%	4.76%	4.33%	3.92%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	8.41%	8.65%	6.67%	6.31%
Cost of Revenue to Revenue	85.28%	85.83%	84.48%	84.50%	84.10%	82.38%	83.82%	83.66%	83.42%	82.72%	82.27%
SG&A Expenses to Revenue	5.84%	6.09%	7.46%	6.93%	7.03%	7.67%	6.66%	6.50%	6.42%	7.49%	7.60%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	6.23%	5.87%	6.79%	6.24%	7.89%	7.21%	6.03%	6.95%	6.63%	8.48%	8.51%
Earnings before Interest and Taxes (EBIT)	320	300	357	412	359	512	576	602	595	515	598
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	466	447	535	608	569	736	832	870	864	796	923
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.25	2.96	3.85	2.74	3.15	3.11	2.91	3.22	2.51	2.79	1.88
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.38	0.38	0.72	0.54	0.72	0.79	0.80	0.86	0.79	0.95	0.66
Price to Earnings (P/E)	8.35	9.06	10.94	10.76	16.64	12.62	12.68	16.23	14.56	20.11	14.79
Dividend Yield	2.68%	2.95%	1.68%	1.84%	1.51%	1.36%	1.36%	1.27%	1.62%	1.46%	1.98%
Earnings Yield	11.98%	11.04%	9.14%	9.29%	6.01%	7.92%	7.88%	6.16%	6.87%	4.97%	6.76%
Enterprise Value to Invested Capital (EV/IC)	1.39	1.46	1.67	1.49	1.72	1.65	1.63	1.84	1.61	1.67	1.36
Enterprise Value to Revenue (EV/Rev)	0.76	0.81	1.33	1.04	1.17	1.37	1.36	1.31	1.26	1.52	1.16
Enterprise Value to EBITDA (EV/EBITDA)	6.12	6.55	10.17	7.64	9.25	9.16	9.27	9.62	8.71	11.14	8.16
Enterprise Value to EBIT (EV/EBIT)	8.92	9.76	15.25	11.27	14.65	13.15	13.39	13.91	12.65	17.23	12.60
Enterprise Value to NOPAT (EV/NOPAT)	13.09	14.76	13.55	14.75	19.05	17.34	17.39	19.35	16.38	21.72	18.04
Enterprise Value to Operating Cash Flow (EV/OCF)	8.50	7.42	13.97	9.17	10.38	11.18	13.86	11.19	15.60	12.29	10.32
Enterprise Value to Free Cash Flow (EV/FCFF)	12.06	11.96	0.00	10.06	16.18	0.00	0.00	13.97	21.85	0.00	41.71
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.37	3.33	3.33	2.62	2.19	2.60	2.43	1.99	1.81	2.08	1.91
Long-Term Debt to Equity	2.13	2.86	3.18	2.42	2.16	2.57	2.41	1.95	1.35	1.72	1.63
Financial Leverage	2.06	2.66	3.26	2.87	2.24	2.15	2.13	1.83	1.56	1.57	1.54
Leverage Ratio	4.79	5.72	6.31	5.60	4.99	5.03	5.07	4.61	4.15	4.18	4.22
Compound Leverage Factor	3.79	4.43	4.24	3.99	3.50	3.99	4.11	3.63	2.94	2.82	2.88
Debt to Total Capital	70.31%	76.89%	76.88%	72.34%	68.68%	72.18%	70.82%	66.59%	64.46%	67.52%	65.65%
Short-Term Debt to Total Capital	7.08%	10.69%	3.28%	5.34%	0.91%	0.62%	0.38%	1.56%	16.56%	11.70%	9.54%
Long-Term Debt to Total Capital	63.23%	66.20%	73.60%	67.00%	67.77%	71.56%	70.44%	65.04%	47.90%	55.82%	56.11%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	29.69%	23.11%	23.12%	27.66%	31.32%	27.82%	29.18%	33.41%	35.54%	32.48%	34.35%
Debt to EBITDA	3.25	3.49	4.76	3.79	3.94	4.42	4.56	3.94	3.97	5.19	4.71
Net Debt to EBITDA	3.03	3.44	4.66	3.67	3.58	3.86	3.80	3.26	3.22	4.16	3.54
Long-Term Debt to EBITDA	2.92	3.01	4.56	3.51	3.89	4.38	4.53	3.84	2.95	4.29	4.03
Debt to NOPAT	6.94	7.88	6.34	7.32	8.12	8.37	8.55	7.92	7.45	10.13	10.41
Net Debt to NOPAT	6.48	7.75	6.21	7.09	7.38	7.31	7.13	6.56	6.05	8.11	7.82
Long-Term Debt to NOPAT	6.24	6.78	6.07	6.78	8.01	8.29	8.50	7.73	5.54	8.37	8.90
Altman Z-Score	2.58	2.50	2.22	2.33	2.35	2.09	2.02	2.41	2.14	1.98	1.87
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.34	1.12	1.35	1.20	1.38	1.51	1.52	1.48	1.02	1.12	1.22
Quick Ratio	0.49	0.36	0.53	0.54	0.70	0.86	0.89	0.86	0.54	0.63	0.68
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	237	245	-852	461	325	-642	-186	599	345	-222	181
Operating Cash Flow to CapEx	142.03%	205.61%	223.45%	265.23%	219.69%	268.76%	242.67%	352.34%	214.43%	283.10%	245.69%
Free Cash Flow to Firm to Interest Expense	3.54	3.61	-7.26	3.88	3.03	-6.10	-1.70	4.69	1.99	-1.33	0.95
Operating Cash Flow to Interest Expense	5.02	5.82	3.32	4.26	4.73	5.72	5.07	5.86	2.78	4.31	3.85
Operating Cash Flow Less CapEx to Interest Expense	1.48	2.99	1.84	2.66	2.57	3.59	2.98	4.19	1.49	2.79	2.29
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.16	1.14	1.05	0.96	0.94	0.86	0.80	0.85	0.80	0.72	0.72
Accounts Receivable Turnover	12.72	12.69	11.01	9.21	8.84	8.75	8.53	9.36	9.52	9.81	10.95
Inventory Turnover	5.45	5.04	5.22	5.54	5.96	6.19	6.45	6.84	5.84	5.18	5.31
Fixed Asset Turnover	3.44	3.17	3.09	2.96	0.00	0.00	0.00	3.27	3.08	2.76	2.78
Accounts Payable Turnover	7.12	6.32	5.93	5.48	5.25	5.30	4.92	5.09	4.87	4.43	4.51
Days Sales Outstanding (DSO)	28.69	28.75	33.15	39.63	41.31	41.70	42.78	38.98	38.32	37.21	33.32
Days Inventory Outstanding (DIO)	66.91	72.45	69.94	65.84	61.27	58.99	56.62	53.36	62.48	70.43	68.71
Days Payable Outstanding (DPO)	51.23	57.79	61.50	66.63	69.58	68.85	74.24	71.70	74.89	82.43	80.87
Cash Conversion Cycle (CCC)	44.38	43.42	41.59	38.84	33.00	31.84	25.16	20.63	25.91	25.20	21.16
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,053	2,006	3,260	3,113	3,064	4,095	4,724	4,558	4,673	5,304	5,540
Invested Capital Turnover	1.83	1.78	1.55	1.40	1.45	1.38	1.29	1.38	1.30	1.17	1.20
Increase / (Decrease) in Invested Capital	-19	-46	1,254	-147	-49	1,031	630	-166	115	630	237
Enterprise Value (EV)	2,853	2,926	5,443	4,643	5,265	6,739	7,716	8,372	7,530	8,873	7,532
Market Capitalization	1,440	1,389	2,950	2,411	3,224	3,897	4,555	5,532	4,746	5,559	4,266
Book Value per Share	$10.58	$7.78	$6.94	$7.97	$9.24	$11.33	$14.15	$15.61	$17.74	$18.63	$21.52
Tangible Book Value per Share	($2.79)	($5.24)	($7.45)	($5.88)	($4.27)	($10.18)	($11.83)	($9.36)	($7.98)	($11.20)	($10.53)
Total Capital	2,153	2,031	3,313	3,186	3,268	4,504	5,356	5,144	5,316	6,126	6,621
Total Debt	1,514	1,562	2,547	2,305	2,244	3,251	3,793	3,425	3,427	4,137	4,347
Total Long-Term Debt	1,361	1,344	2,439	2,134	2,215	3,223	3,773	3,345	2,546	3,420	3,715
Net Debt	1,414	1,537	2,494	2,232	2,041	2,842	3,162	2,840	2,784	3,314	3,266
Capital Expenditures (CapEx)	236	192	174	191	231	224	229	212	225	255	297
Debt-free, Cash-free Net Working Capital (DFCFNWC)	316	293	389	308	214	226	176	189	275	169	91
Debt-free Net Working Capital (DFNWC)	416	317	442	381	418	636	808	775	917	992	1,172
Net Working Capital (NWC)	264	100	334	211	388	608	787	695	37	275	540
Net Nonoperating Expense (NNE)	46	45	132	91	83	80	85	92	134	132	129
Net Nonoperating Obligations (NNO)	1,414	1,537	2,494	2,232	2,041	2,842	3,162	2,840	2,784	3,314	3,266
Total Depreciation and Amortization (D&A)	146	147	178	196	210	224	256	268	269	281	325
Debt-free, Cash-free Net Working Capital to Revenue	8.41%	8.10%	9.51%	6.93%	4.77%	4.59%	3.10%	2.95%	4.58%	2.89%	1.40%
Debt-free Net Working Capital to Revenue	11.06%	8.79%	10.82%	8.57%	9.31%	12.91%	14.23%	12.09%	15.32%	16.95%	18.07%
Net Working Capital to Revenue	7.02%	2.78%	8.16%	4.74%	8.65%	12.34%	13.87%	10.84%	0.62%	4.70%	8.33%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.83	$2.56	$2.44	$2.03	$1.75	$2.79	$3.25	$3.09	$3.00	$2.59	$2.71
Adjusted Weighted Average Basic Shares Outstanding	60.39M	55.05M	110.39M	110.43M	110.78M	110.06M	110.41M	110.08M	106.50M	106.79M	105.44M
Adjusted Diluted Earnings per Share	$2.81	$2.55	$2.42	$2.01	$1.74	$2.77	$3.23	$3.07	$2.98	$2.58	$2.70
Adjusted Weighted Average Diluted Shares Outstanding	60.39M	55.05M	110.39M	110.43M	110.78M	110.06M	110.41M	110.08M	106.50M	106.79M	105.44M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	60.39M	55.05M	110.39M	110.43M	110.78M	110.06M	110.41M	110.08M	106.50M	106.79M	105.44M
Normalized Net Operating Profit after Tax (NOPAT)	228	193	231	291	306	371	416	453	470	455	459
Normalized NOPAT Margin	6.05%	5.34%	5.64%	6.55%	6.81%	7.55%	7.33%	7.07%	7.84%	7.77%	7.07%
Pre Tax Income Margin	6.72%	6.42%	5.86%	6.59%	5.62%	8.27%	8.21%	7.40%	7.05%	5.94%	6.30%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.78	4.42	3.04	3.47	3.35	4.87	5.25	4.71	3.44	3.08	3.16
NOPAT to Interest Expense	3.26	2.92	3.42	2.65	2.57	3.69	4.04	3.39	2.65	2.44	2.20
EBIT Less CapEx to Interest Expense	1.25	1.59	1.56	1.86	1.20	2.74	3.16	3.05	2.14	1.55	1.59
NOPAT Less CapEx to Interest Expense	-0.27	0.09	1.94	1.04	0.42	1.56	1.95	1.72	1.35	0.92	0.64
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	23.05%	26.66%	15.02%	19.89%	26.23%	17.38%	17.40%	21.11%	24.20%	29.69%	29.74%
Augmented Payout Ratio	123.40%	209.72%	16.55%	23.38%	40.47%	31.02%	19.79%	34.35%	80.65%	33.06%	55.71%

This table displays calculated financial ratios and metrics derived from Silgan's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	105,441,971.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	105,441,971.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0.60
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-8.49%	-7.92%	-7.14%	-3.18%	-3.22%	5.30%	11.36%	11.42%	15.11%	4.07%	6.45%
EBITDA Growth	-8.37%	36.58%	-9.07%	-1.53%	-9.73%	-10.86%	17.73%	17.25%	20.17%	6.25%	0.87%
EBIT Growth	-11.54%	55.43%	-14.87%	-1.49%	-13.81%	-25.28%	16.85%	18.10%	18.75%	7.32%	-3.03%
NOPAT Growth	-10.79%	126.65%	-15.71%	-8.10%	-8.73%	-11.57%	18.01%	16.03%	12.66%	-61.34%	-6.52%
Net Income Growth	-20.25%	161.96%	-23.41%	-3.54%	-9.55%	-30.06%	23.20%	16.88%	13.23%	-59.60%	-7.24%
EPS Growth	-18.40%	160.87%	-20.00%	0.00%	-8.82%	-30.00%	21.15%	16.90%	13.98%	-57.14%	-4.76%
Operating Cash Flow Growth	-7.98%	24.56%	13.29%	111.61%	45.12%	-13.25%	-24.75%	-1,159.72%	8.90%	38.26%	-17.00%
Free Cash Flow Firm Growth	-233.55%	-108.58%	71.14%	259.23%	229.36%	-2,931.56%	-1,736.09%	-469.19%	-464.89%	62.59%	88.11%
Invested Capital Growth	7.52%	2.53%	0.67%	-4.09%	-3.37%	13.49%	16.22%	25.13%	24.34%	4.47%	2.94%
Revenue Q/Q Growth	26.38%	-25.68%	-1.72%	4.88%	26.33%	-19.14%	3.93%	4.94%	30.51%	-26.89%	6.31%
EBITDA Q/Q Growth	23.01%	-25.60%	-4.83%	16.27%	12.77%	-26.53%	22.22%	15.80%	15.58%	-35.05%	16.03%
EBIT Q/Q Growth	34.79%	-35.02%	-11.42%	26.97%	17.93%	-43.67%	38.53%	28.33%	18.58%	-49.09%	25.18%
NOPAT Q/Q Growth	25.12%	-33.55%	-13.20%	27.34%	24.26%	-35.62%	15.83%	25.20%	20.66%	-77.90%	180.06%
Net Income Q/Q Growth	40.22%	-41.75%	-14.38%	37.95%	31.48%	-54.96%	50.81%	30.87%	27.38%	-83.93%	246.29%
EPS Q/Q Growth	43.66%	-41.18%	-13.33%	36.54%	30.99%	-54.84%	50.00%	31.75%	27.71%	-83.02%	233.33%
Operating Cash Flow Q/Q Growth	219.85%	400.05%	-150.79%	103.81%	1,397.94%	198.94%	-173.03%	67.60%	253.93%	279.54%	-161.80%
Free Cash Flow Firm Q/Q Growth	-16.15%	92.86%	368.11%	615.74%	-5.64%	-267.42%	-44.69%	-61.51%	6.74%	82.83%	54.00%
Invested Capital Q/Q Growth	-1.93%	-17.80%	17.08%	1.61%	-1.19%	-3.46%	19.90%	9.40%	-1.82%	-18.89%	18.14%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	15.86%	16.31%	16.97%	18.53%	16.81%	16.94%	18.44%	19.43%	16.29%	17.21%	17.02%
EBITDA Margin	14.46%	14.47%	13.63%	15.11%	13.49%	12.25%	14.41%	15.90%	14.08%	12.51%	13.65%
Operating Margin	10.76%	9.41%	8.48%	10.27%	9.59%	6.68%	8.90%	10.88%	9.89%	6.89%	8.11%
EBIT Margin	10.76%	9.41%	8.48%	10.27%	9.59%	6.68%	8.90%	10.88%	9.89%	6.89%	8.11%
Profit (Net Income) Margin	6.13%	4.81%	4.19%	5.51%	5.73%	3.19%	4.63%	5.78%	5.64%	1.24%	4.04%
Tax Burden Percent	75.34%	77.04%	75.49%	75.71%	79.78%	92.59%	77.57%	74.85%	76.20%	34.10%	74.92%
Interest Burden Percent	75.65%	66.31%	65.41%	70.86%	74.97%	51.65%	67.12%	70.93%	74.84%	52.79%	66.47%
Effective Tax Rate	24.66%	22.96%	24.51%	24.29%	20.22%	8.82%	23.76%	25.62%	24.32%	67.15%	26.51%
Return on Invested Capital (ROIC)	9.02%	9.41%	6.91%	8.00%	7.91%	7.15%	6.89%	7.97%	7.81%	2.70%	6.08%
ROIC Less NNEP Spread (ROIC-NNEP)	8.07%	8.24%	6.11%	7.17%	7.00%	5.81%	6.08%	7.12%	6.88%	2.25%	5.37%
Return on Net Nonoperating Assets (RNNOA)	17.42%	12.85%	11.98%	14.23%	13.41%	9.13%	11.99%	14.32%	12.72%	3.47%	10.36%
Return on Equity (ROE)	26.44%	22.26%	18.90%	22.23%	21.32%	16.27%	18.87%	22.29%	20.52%	6.17%	16.44%
Cash Return on Invested Capital (CROIC)	0.21%	7.47%	7.48%	11.84%	10.99%	-4.45%	-7.84%	-15.28%	-14.28%	3.33%	3.48%
Operating Return on Assets (OROA)	8.57%	7.54%	6.47%	7.69%	7.13%	4.83%	6.54%	7.84%	7.37%	4.97%	5.90%
Return on Assets (ROA)	4.88%	3.85%	3.19%	4.12%	4.26%	2.31%	3.41%	4.16%	4.20%	0.89%	2.94%
Return on Common Equity (ROCE)	26.44%	22.26%	18.90%	22.23%	21.32%	16.27%	18.87%	22.29%	20.52%	6.17%	16.44%
Return on Equity Simple (ROE_SIMPLE)	16.06%	0.00%	16.27%	15.84%	14.40%	0.00%	13.88%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	146	97	84	107	133	86	100	125	150	33	93
NOPAT Margin	8.11%	7.25%	6.40%	7.77%	7.65%	6.09%	6.79%	8.10%	7.48%	2.26%	5.96%
Net Nonoperating Expense Percent (NNEP)	0.95%	1.16%	0.81%	0.83%	0.91%	1.34%	0.80%	0.85%	0.93%	0.46%	0.71%
Return On Investment Capital (ROIC_SIMPLE)	-	1.83%	-	-	-	1.40%	1.48%	1.71%	2.08%	0.50%	1.33%
Cost of Revenue to Revenue	84.14%	83.69%	83.03%	81.47%	83.19%	83.06%	81.56%	80.57%	83.71%	82.79%	82.98%
SG&A Expenses to Revenue	4.68%	7.21%	7.63%	7.80%	6.10%	8.77%	8.80%	7.92%	6.08%	8.14%	8.40%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	5.09%	6.90%	8.49%	8.26%	7.22%	10.26%	9.54%	8.55%	6.40%	10.32%	8.91%
Earnings before Interest and Taxes (EBIT)	194	126	112	142	167	94	131	168	199	101	127
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	261	194	179	209	235	173	211	245	283	184	213
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.62	2.51	2.71	2.34	2.73	2.79	2.62	2.61	2.03	1.88	1.76
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.76	0.79	0.88	0.77	0.97	0.95	0.91	0.94	0.72	0.66	0.62
Price to Earnings (P/E)	16.30	14.56	16.66	14.76	18.96	20.11	18.88	19.19	14.60	14.79	14.43
Dividend Yield	1.65%	1.62%	1.51%	1.75%	1.43%	1.46%	1.51%	1.44%	1.84%	1.98%	2.09%
Earnings Yield	6.14%	6.87%	6.00%	6.78%	5.28%	4.97%	5.30%	5.21%	6.85%	6.76%	6.93%
Enterprise Value to Invested Capital (EV/IC)	1.51	1.61	1.59	1.47	1.65	1.67	1.53	1.51	1.34	1.36	1.27
Enterprise Value to Revenue (EV/Rev)	1.40	1.26	1.48	1.39	1.56	1.52	1.62	1.71	1.43	1.16	1.26
Enterprise Value to EBITDA (EV/EBITDA)	10.60	8.71	10.31	9.66	11.06	11.14	11.75	12.19	10.05	8.16	9.00
Enterprise Value to EBIT (EV/EBIT)	15.56	12.65	15.15	14.20	16.54	17.23	18.23	18.82	15.50	12.60	14.00
Enterprise Value to NOPAT (EV/NOPAT)	20.94	16.38	19.64	18.73	21.40	21.72	22.98	23.90	20.05	18.04	20.23
Enterprise Value to Operating Cash Flow (EV/OCF)	31.74	15.60	15.40	10.61	10.46	12.29	16.60	30.62	24.64	10.32	13.55
Enterprise Value to Free Cash Flow (EV/FCFF)	748.89	21.85	21.38	12.12	14.72	0.00	0.00	0.00	0.00	41.71	37.08
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.36	1.81	2.04	2.03	1.85	2.08	2.22	2.27	2.18	1.91	2.01
Long-Term Debt to Equity	1.86	1.35	1.33	1.31	1.24	1.72	1.67	1.40	1.68	1.63	1.58
Financial Leverage	2.16	1.56	1.96	1.98	1.91	1.57	1.97	2.01	1.85	1.54	1.93
Leverage Ratio	4.41	4.15	4.19	4.10	4.06	4.18	4.10	4.12	3.99	4.22	4.11
Compound Leverage Factor	3.34	2.75	2.74	2.91	3.04	2.16	2.75	2.92	2.98	2.23	2.73
Debt to Total Capital	70.26%	64.46%	67.13%	67.02%	64.96%	67.52%	68.96%	69.45%	68.52%	65.65%	66.76%
Short-Term Debt to Total Capital	14.98%	16.56%	23.28%	23.85%	21.40%	11.70%	17.06%	26.63%	15.72%	9.54%	14.16%
Long-Term Debt to Total Capital	55.28%	47.90%	43.85%	43.17%	43.56%	55.82%	51.90%	42.82%	52.80%	56.11%	52.60%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	29.74%	35.54%	32.87%	32.98%	35.04%	32.48%	31.04%	30.55%	31.48%	34.35%	33.24%
Debt to EBITDA	5.21	3.97	4.59	4.66	4.66	5.19	5.59	5.85	5.43	4.71	5.04
Net Debt to EBITDA	4.83	3.22	4.22	4.30	4.21	4.16	5.16	5.48	5.00	3.54	4.57
Long-Term Debt to EBITDA	4.10	2.95	3.00	3.00	3.12	4.29	4.21	3.60	4.18	4.03	3.97
Debt to NOPAT	10.29	7.45	8.73	9.03	9.01	10.13	10.93	11.47	10.83	10.41	11.34
Net Debt to NOPAT	9.54	6.05	8.04	8.34	8.14	8.11	10.09	10.75	9.98	7.82	10.28
Long-Term Debt to NOPAT	8.10	5.54	5.71	5.82	6.04	8.37	8.22	7.07	8.35	8.90	8.93
Altman Z-Score	2.01	1.94	1.98	1.91	2.05	1.82	1.82	1.70	1.74	1.69	1.73
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.39	1.02	1.04	1.06	1.09	1.12	1.14	0.96	1.27	1.22	1.26
Quick Ratio	0.84	0.54	0.55	0.57	0.68	0.63	0.60	0.50	0.77	0.68	0.68
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-251	-18	48	345	325	-544	-788	-1,272	-1,187	-204	-94
Operating Cash Flow to CapEx	397.28%	2,026.37%	-752.87%	37.52%	518.63%	1,414.07%	-824.65%	-350.01%	426.67%	1,821.83%	-994.78%
Free Cash Flow to Firm to Interest Expense	-5.32	-0.42	1.25	8.34	7.77	-11.95	-18.35	-26.13	-23.74	-4.27	-2.21
Operating Cash Flow to Interest Expense	4.56	25.38	-14.17	0.51	7.48	20.54	-15.92	-4.55	6.82	27.10	-18.84
Operating Cash Flow Less CapEx to Interest Expense	3.42	24.13	-16.06	-0.84	6.03	19.08	-17.85	-5.85	5.22	25.61	-20.73
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.80	0.80	0.76	0.75	0.74	0.72	0.73	0.72	0.75	0.72	0.73
Accounts Receivable Turnover	5.04	9.52	6.26	5.50	4.62	9.81	6.13	5.36	4.74	10.95	6.06
Inventory Turnover	5.76	5.84	4.88	4.30	5.64	5.18	4.91	4.47	5.87	5.31	4.98
Fixed Asset Turnover	3.21	3.08	3.04	3.02	2.99	2.76	2.83	2.86	2.95	2.78	2.82
Accounts Payable Turnover	7.61	4.87	7.40	6.89	7.20	4.43	7.35	7.15	6.91	4.51	6.99
Days Sales Outstanding (DSO)	72.36	38.32	58.35	66.37	79.08	37.21	59.54	68.08	77.06	33.32	60.25
Days Inventory Outstanding (DIO)	63.38	62.48	74.81	84.80	64.72	70.43	74.26	81.65	62.20	68.71	73.36
Days Payable Outstanding (DPO)	47.99	74.89	49.31	52.97	50.67	82.43	49.69	51.05	52.79	80.87	52.20
Cash Conversion Cycle (CCC)	87.74	25.91	83.85	98.20	93.13	25.20	84.11	98.68	86.47	21.16	81.42
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	5,685	4,673	5,472	5,560	5,494	5,304	6,359	6,957	6,830	5,540	6,546
Invested Capital Turnover	1.11	1.30	1.08	1.03	1.03	1.17	1.02	0.98	1.04	1.20	1.02
Increase / (Decrease) in Invested Capital	398	115	36	-237	-192	630	887	1,397	1,337	237	187
Enterprise Value (EV)	8,567	7,530	8,723	8,146	9,045	8,873	9,735	10,532	9,160	7,532	8,316
Market Capitalization	4,663	4,746	5,151	4,520	5,606	5,559	5,459	5,797	4,602	4,266	4,091
Book Value per Share	$16.21	$17.74	$17.84	$18.11	$19.24	$18.63	$19.51	$20.77	$21.24	$21.52	$22.01
Tangible Book Value per Share	($8.39)	($7.98)	($7.51)	($6.92)	($6.10)	($11.20)	($11.05)	($10.93)	($10.29)	($10.53)	($9.71)
Total Capital	5,992	5,316	5,780	5,863	5,862	6,126	6,712	7,274	7,220	6,621	6,981
Total Debt	4,210	3,427	3,880	3,929	3,808	4,137	4,629	5,052	4,947	4,347	4,660
Total Long-Term Debt	3,313	2,546	2,535	2,531	2,554	3,420	3,483	3,115	3,812	3,715	3,672
Net Debt	3,903	2,784	3,572	3,626	3,440	3,314	4,276	4,735	4,558	3,266	4,225
Capital Expenditures (CapEx)	54	53	73	56	60	66	83	63	80	71	80
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,337	275	1,124	1,238	1,100	169	1,104	1,494	1,407	91	1,162
Debt-free Net Working Capital (DFNWC)	1,644	917	1,433	1,541	1,468	992	1,457	1,812	1,796	1,172	1,597
Net Working Capital (NWC)	746	37	87	143	214	275	312	-126	661	540	609
Net Nonoperating Expense (NNE)	36	33	29	31	33	41	32	36	37	15	30
Net Nonoperating Obligations (NNO)	3,903	2,784	3,572	3,626	3,440	3,314	4,276	4,735	4,558	3,266	4,225
Total Depreciation and Amortization (D&A)	67	68	68	67	68	79	81	77	84	83	87
Debt-free, Cash-free Net Working Capital to Revenue	21.90%	4.58%	19.09%	21.19%	19.01%	2.89%	18.39%	24.25%	21.90%	1.40%	17.66%
Debt-free Net Working Capital to Revenue	26.94%	15.32%	24.34%	26.38%	25.38%	16.95%	24.27%	29.40%	27.96%	18.07%	24.28%
Net Working Capital to Revenue	12.23%	0.62%	1.48%	2.44%	3.70%	4.70%	5.20%	-2.04%	10.29%	8.33%	9.26%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.02	$0.61	$0.52	$0.71	$0.94	$0.42	$0.64	$0.83	$1.06	$0.18	$0.60
Adjusted Weighted Average Basic Shares Outstanding	108.42M	106.50M	106.65M	106.84M	106.85M	106.79M	106.92M	107.05M	106.62M	105.44M	105.59M
Adjusted Diluted Earnings per Share	$1.02	$0.60	$0.52	$0.71	$0.93	$0.42	$0.63	$0.83	$1.06	$0.18	$0.60
Adjusted Weighted Average Diluted Shares Outstanding	108.75M	106.50M	107.05M	107.02M	107.14M	106.79M	107.34M	107.25M	106.80M	105.44M	105.86M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	106.50M	106.50M	106.78M	106.78M	106.79M	106.79M	106.99M	106.99M	105.67M	105.44M	105.68M
Normalized Net Operating Profit after Tax (NOPAT)	152	94	93	112	149	105	108	132	155	93	99
Normalized NOPAT Margin	8.42%	7.01%	7.05%	8.13%	8.54%	7.44%	7.35%	8.57%	7.73%	6.35%	6.34%
Pre Tax Income Margin	8.14%	6.24%	5.55%	7.28%	7.19%	3.45%	5.97%	7.72%	7.40%	3.64%	5.39%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.11	2.97	2.89	3.43	4.00	2.07	3.04	3.44	3.97	2.12	2.98
NOPAT to Interest Expense	3.09	2.29	2.18	2.60	3.19	1.89	2.32	2.56	3.01	0.70	2.19
EBIT Less CapEx to Interest Expense	2.96	1.72	1.01	2.08	2.55	0.62	1.11	2.14	2.38	0.63	1.09
NOPAT Less CapEx to Interest Expense	1.95	1.03	0.30	1.25	1.75	0.43	0.39	1.26	1.41	-0.79	0.30
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	27.03%	24.20%	25.71%	26.09%	27.37%	29.69%	28.65%	27.80%	26.99%	29.74%	30.58%
Augmented Payout Ratio	93.31%	80.65%	83.38%	78.57%	30.00%	33.06%	31.60%	30.60%	48.47%	55.71%	57.34%

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways from Silgan Holdings (SLGN) based on the latest quarterly filings and the last four years of data provided. The focus is on trends in revenue, profitability, cash flow, and balance-sheet strength to help retail investors gauge the company’s trajectory.

The bullets below are ordered with positive items first, followed by neutral observations, and ending with the main negative item.

All four 2025 quarters produced positive net income. Q1: $67.96M, Q2: $88.94M, Q3: $113.29M, Q4: $18.20M.
Operating cash flow from continuing operations turned positive in Q4 2025. Q4 CFO: $1.293B; Q3 CFO was $340.89M, with CFO improving over the year.
Free cash flow in Q4 2025 appears robust. Approximately $1.22B of cash generated after ~\$71M in capital expenditures.
Gross margins stayed in the mid-teens across 2025. Examples: Q2 margin ≈ 19.4%, Q3 ≈ 16.3%, Q4 ≈ 17.2%, Q1 ≈ 18.4% (gross profit vs. revenue).
Cash dividends per share remained steady around $0.20. 2025 quarters show a consistent payout policy.
Liquidity remained solid. In 2025, current assets typically ran around $3.1–3.7B vs. current liabilities around $2.4–2.6B (example: Q3 2025 current assets $3.112B vs. current liabilities $2.450B).
Asset base showing growth. Total assets rose to about \$9.50B by 2025 Q3, up from roughly \$7.75B in 2024 Q3 — a sign of expansion.
Leverage remains sizable. Long-term debt generally in the \$3.0–3.8B range and total liabilities above \$7.0B across 2025; this indicates ongoing debt obligations to monitor but is not an immediate distress signal.
Capital expenditures are moderate. Quarterly purchases of PPE and related capex are typically in the tens of millions (roughly \$50–\$80M range in 2025), suggesting steady capacity maintenance rather than aggressive expansion.
Q4 2025 net income declined due to one-time charges. Net income dropped to \$18.2M as restructuring charges (~\$32.5M) and other items weighed on quarterly results.

05/14/26 08:57 AM ETAI Generated. May Contain Errors.

Silgan Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Silgan's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Silgan's net income appears to be on an upward trend, with a most recent value of $288.40 million in 2025, rising from $172.41 million in 2015. The previous period was $276.38 million in 2024. Find out what analysts predict for Silgan in the coming months.

Silgan's total operating income in 2025 was $597.87 million, based on the following breakdown:

Total Gross Profit: $1.15 billion
Total Operating Expenses: $551.56 million

Over the last 10 years, Silgan's total revenue changed from $3.76 billion in 2015 to $6.48 billion in 2025, a change of 72.2%.

Silgan's total liabilities were at $7.12 billion at the end of 2025, a 8.0% increase from 2024, and a 178.9% increase since 2015.

In the past 10 years, Silgan's cash and equivalents has ranged from $24.69 million in 2016 to $1.08 billion in 2025, and is currently $1.08 billion as of their latest financial filing in 2025.

Over the last 10 years, Silgan's book value per share changed from 10.58 in 2015 to 21.52 in 2025, a change of 103.4%.

Related Companies

Financial statements for NYSE:SLGN last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Silgan (SLGN) Financials

Financials Breakdown Chart

Key Financial Trends

Silgan Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Silgan (SLGN) Financials

Annual Income Statements for Silgan

Quarterly Income Statements for Silgan

Annual Cash Flow Statements for Silgan

Quarterly Cash Flow Statements for Silgan

Annual Balance Sheets for Silgan

Quarterly Balance Sheets for Silgan

Annual Metrics And Ratios for Silgan

Quarterly Metrics And Ratios for Silgan

Financials Breakdown Chart

Key Financial Trends

Silgan Financials - Frequently Asked Questions

When does Silgan's financial year end?

How has Silgan's net income changed over the last 10 years?

What is Silgan's operating income?

How has Silgan's revenue changed over the last 10 years?

How much debt does Silgan have?

How much cash does Silgan have?

How has Silgan's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools